This inventor holds 2 USPTO granted patents. Top assignee: Yale University. Active years: 2007-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2010
Title: The Innovative Mind of David J. Austin
Introduction
David J. Austin is a distinguished inventor based in New York, NY, whose contributions to the field of pharmaceuticals are noteworthy. With a total of two patents to his name, his work focuses on developing novel antiviral compounds and therapeutic methods for treating various diseases.
Latest Patents
Among his latest inventions is a patent for antiviral helioxanthin analogs. This groundbreaking work relates to novel compounds that show potential in the treatment of infections caused by hepadnaviruses, flaviviruses, herpesviruses, and human immunodeficiency virus (HIV). The compounds not only aim to combat viral infections but also address the prevention and reduction of tumors that may arise from such infections and other disease states.
Austin's second patent pertains to compounds and methods for treating tumors, cancer, and hyperproliferative diseases. This innovative patent covers pharmaceutical compositions designed to tackle conditions such as psoriasis, genital warts, and various hyperproliferative cell growth diseases like hyperkeratosis and ichthyosis.
Career Highlights
David J. Austin holds a position at Yale University, a prestigious institution known for its commitment to research and innovation. His work at the university emphasizes the intersection of science and practical applications, particularly in the realm of health and medicine.
Collaborations
Throughout his career, Austin has collaborated with notable researchers, including Viet-Ahn A. Nguyen and Doris Pupowicz. These partnerships have fostered a rich environment for innovation and the advancement of medical science.
Conclusion
David J. Austin exemplifies the spirit of innovation in the pharmaceutical industry. Through his patents and collaborative efforts, he continues to make significant strides in the development of antiviral therapies and cancer treatments. His contributions are poised to impact both current and future medical practices.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
